• Sunday, Sep 25, 2022
  • Last Update : 10:24 am
Gilead cuts 2020 sales outlook as Covid-19...

Gilead cuts 2020 sales outlook

North America

Thu, Oct 29 2020

Many US doctors remain wary of using remdesivir in Covid-19 patients with less severe illness

Gilead prices Covid-19 drug candidate...

Gilead prices Covid-19 drug candidate...

Coronavirus

Mon, Jun 29 2020

The per-vial price outside of private insurance will be $390, Gilead added

US group raises pricing recommendation...

US group raises pricing recommendation...

North America

Thu, Jun 25 2020

What Gilead could charge for remdesivir in the United States after its pledged donations are used up...

Covid-19: Gilead to test inhaled version...

Covid-19: Gilead to test inhaled version...

Coronavirus

Mon, Jun 22 2020

It plans to make over 2m courses of the potential Covid-19 drug by 2020

AstraZeneca contacted Gilead over potential...

AstraZeneca contacted Gilead over potential...

World

Mon, Jun 8 2020

Gilead has been in the vanguard of Covid-19 treatments

Covid-19: Gilead's developing inhaled...

Covid-19: Gilead's developing inhaled...

Coronavirus

Tue, Jun 2 2020

Roche and Eli Lilly and Co are testing drugs in combination with remdesivir for critically ill...

India approves emergency use of remdesivir...

India approves emergency use of remdesivir...

South Asia

Tue, Jun 2 2020

'(Remdesivir) approved on June 1 under emergency use with condition for five dose...

Gilead says remdesivir helped moderate...

Gilead says remdesivir helped moderate...

World

Mon, Jun 1 2020

Those results were seen as particularly significant as there are no approved drugs or vaccines for the...